Netflix just dropped its Q2 results, and the numbers are big. Revenue jumped 16%, hitting over $11 billion. Earnings per share beat Wall Street’s guesses, too. But here’s the twist: the Netflix stock still dipped after the news. Surprised? So were we.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
On Monday, AbbVie announced a major deal to buy Capstan Therapeutics for up to $2.1 billion in cash. This move boosts AbbVie’s lineup of new treatments, focusing on autoimmune diseases, as its top drug, Humira, loses steam. Capstan brings exciting CAR-T therapies to the table, targeting conditions that affect millions. Continue Reading on Meyka This…
Intraday IVP stock: **$0.0788**, **1.61B** volume on NASDAQ; quick technical and fundamental IVP stock outlook
INTO stock analysis: Initio Inc (INTO) at $0.20 shows an oversold bounce setup with Meyka AI forecast and risks
ISUNQ stock plunged 99.00% to USD 0.000001 on 23 Jan 2026; we review drivers, risks and a bold forecast for investors
OSS stock update: One Stop Systems (NASDAQ) at $9.20 pre-market on 26 Feb 2026 with a 12-month Meyka forecast of $11.76 and a 27.85% implied upside
BKKT-WT stock slides pre-market Jan 26 2026; Meyka AI grade B and model forecast show wide variance vs current price